Editorial: Are inflammatory biomarkers following bioresorbable scaffold or drug-eluting stent implantation directly linked to outcomes?

Patrick W. Serruys; Kotaro Miyashita; Scot Garg; Yoshinobu Onuma

doi:10.1016/j.carrev.2024.01.010

Related publications

Article2011

SIX MONTH CLINICAL OUTCOMES FOLLOWING THE IMPLANTATION OF THE BIORESORBABLE EVEROLIMUS ELUTING VASCULAR SCAFFOLD IN VESSELS SMALLER OR LARGER THAN 2.5 MM

Roberto Diletti, Yoshinobu Onuma, Vasim Farooq, Josep Gómez‐Lara, Salvatore Brugaletta, Robert‐Jan van Geuns, Evelyn Regar, Bernard De Bruyne, Dariusz Dudek, Leif Thuesen, Bernard Chevalier, Dougal McClean, Stephan Windecker, Robert Whitbourne, Li Dong, Susan Veldhof, Richard Rapoza, Krishnakutty Sudhir, Héctor M. García‐García, John A. Ormiston, Patrick W. Serruys

Journal of the American College of Cardiology

Article2019

Sex differences in clinical outcomes following bioresorbable scaffold implantation: a paradigm shift?

Christos V. Bourantas, Retesh Bajaj, Vincenzo Tufaro, Yakup Kilic, Patrick W. Serruys

EuroIntervention

Article2013

TCT-564 Implications of the local hemodynamic forces on vessel wall responses following drug-eluting bioresorbable vascular scaffold implantation: an optical coherence tomography analysis

Christos V. Bourantas, Michail I. Papafaklis, Anna Kotsia, Vasim Farooq, Cécile Dorange, Dimitrios I. Fotiadis, Josep Gómez‐Lara, Lampros K. Michalis, Takashi Muramatsu, Katerina Κ. Naka, Yoshinobu Onuma, Richard Rapoza, Héctor M. García‐García, Patrick W. Serruys

Journal of the American College of Cardiology

Article2004

1024-54 Low repeat revascularization rates following drug-eluting stent implantation in de novo bifurcation lesions

Angela Hoye, Pedro A. Lemos, Kengo Tanabe, Chourmouzios A. Arampatzis, Francesco Saia, Jiro Aoki, Muzaffer Değertekin, Andrew T.L. Ong, Carlos A.G. van Mieghem, Sjoerd H. Hofma, Georgios Sianos, Pieter C. Smits, Willem van der Giessen, Eugène McFadden, Pim de Feyter, Patrick W. Serruys

Journal of the American College of Cardiology

Article2022

TCTAP A-072 Immediate Effect of Percutaneous Coronary Intervention by Bioresorbable Scaffold or Drug-Eluting Stent on Superficial Wall Strain of Stenotic Coronary Arteries

Xinlei Wu, Mick Renkens, Laura S.M. Kerkmeijer, Neil O’Leary, Mattia Lunardi, Jiayue Huang, Daixin Ding, Robbert de Winter, Yoshinobu Onuma, Patrick W. Serruys, William Wijns, Joanna J. Wykrzykowska, Shengxian Tu

Journal of the American College of Cardiology

Editorial: Are inflammatory biomarkers following bioresorbable scaffold or drug-eluting stent implantation directly linked to outcomes?

Abstract

Discussion(0)

Related publications

SIX MONTH CLINICAL OUTCOMES FOLLOWING THE IMPLANTATION OF THE BIORESORBABLE EVEROLIMUS ELUTING VASCULAR SCAFFOLD IN VESSELS SMALLER OR LARGER THAN 2.5 MM

Sex differences in clinical outcomes following bioresorbable scaffold implantation: a paradigm shift?

TCT-564 Implications of the local hemodynamic forces on vessel wall responses following drug-eluting bioresorbable vascular scaffold implantation: an optical coherence tomography analysis

1024-54 Low repeat revascularization rates following drug-eluting stent implantation in de novo bifurcation lesions

TCTAP A-072 Immediate Effect of Percutaneous Coronary Intervention by Bioresorbable Scaffold or Drug-Eluting Stent on Superficial Wall Strain of Stenotic Coronary Arteries